Inventor · disambiguated record
Hanspeter Waldner
Also filed as: WALDNER HANSPETER
5 granted patents·4 pending applications·148 citations·filing 2003–2023
84Inventor score
Files withBRIGHAM & WOMENS HOSPITAL2CRISPR THERAPEUTICS AG2KUCHROO VIJAY K2BRIGHAM & WOMENS HOSPITAL INC1DANA FARBER CANCER INST INC1
Top patents by PatentIndex Score
9 records- 0195US8101176B2Compositions and methods related to TIM-3, a TH1-specific cell surface moleculeKUCHROO VIJAY K·Filed 2008·Granted Jan 24, 2012·46 cites·20 claims
- 0294US9333256B2Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cellsBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted May 10, 2016·21 cites·10 claims
- 0394US7470428B2Compositions and methods related to TIM-3, a Th1-specific cell surface moleculeBRIGHAM & WOMENS HOSPITAL·Filed 2003·Granted Dec 30, 2008·59 cites·10 claims
- 0493US8697069B2Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cellsKUCHROO VIJAY K·Filed 2011·Granted Apr 15, 2014·22 cites·11 claims
- 0564US2018271977A1Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cellsBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Application pending·0 cites
- 0663US2014242094A1Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cellsDANA FARBER CANCER INST INC·Filed 2014·Application pending·0 cites
- 0763US2023346836A1Genetically engineered t cells with disrupted casitas b-lineage lymphoma proto-oncogene-b (cblb) and uses thereofCRISPR THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0859US2023390392A1Multiplex gene edited cells for cd70-directed cancer immunotherapyNKARTA INC·Filed 2023·Application pending·0 cites
- 0955US12344656B2Genetically engineered T cells having improved persistence in cultureCRISPR THERAPEUTICS AG·Filed 2020·Granted Jul 1, 2025·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Hanspeter Waldner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →